Wan‐Long Chuang

机构：Kaohsiung Medical University, Kaohsiung Medical University Chung-Ho Memorial Hospital · ORCID：0000-0002-2376-421X

发表论文 872 篇 · 总被引 23455 次 · h-index 68

代表论文

• Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection (2026 · New England Journal of Medicine · 被引 8)
• Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication (2025 · Alimentary Pharmacology & Therapeutics · 被引 5)
• Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B (2026 · Journal of the Formosan Medical Association · 被引 2)
• Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus (2025 · The American Journal of Gastroenterology · 被引 2)
• Editorial: Liver and Non‐Liver Outcomes Between Different Subtypes of Steatotic Liver Disease (2026 · Alimentary Pharmacology & Therapeutics · 被引 1)
• A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B (2026 · Hepatology)